文献速递乳腺外科

对侧预防性乳房切除术使用增加但未改善浸润性乳腺癌长期生存

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
PubMed 文献 · Ann Surg · 2017-01-01

该研究基于SEER登记数据,分析1998-2012年单侧I-III期浸润性乳腺癌患者,比较保乳手术、单侧乳房切除术和对侧预防性乳房切除术(CPM)的趋势与生存。结果显示CPM比例从2002年3.9%升至2012年12.7%,但与保乳治疗相比,CPM未显著改善乳腺癌特异性生存或总生存,无论激素受体状态或年龄。

要点

  • CPM使用率从2002年3.9%增至2012年12.7%,增长超过三倍。
  • 与保乳治疗相比,CPM未显著改善乳腺癌特异性生存或总生存。
  • CPM患者重建手术率48.3%,高于单侧乳房切除术的16.0%。

核心结论

  • CPM使用在研究期间增长超过三倍,但证据提示相较于保乳治疗无生存获益。
  • 需进一步研究如何最佳地向女性咨询手术选择。

研究设计与样本

  • 基于SEER登记数据的回顾性队列研究,纳入1998-2012年单侧I-III期浸润性乳腺癌女性。
  • 共496,488例患者,比较保乳手术、单侧乳房切除术和CPM的特征与时间趋势。
  • 对1998-2007年诊断患者进行Cox比例风险回归,分析乳腺癌特异性生存和总生存,并按年龄和激素受体状态分层。

主要发现

  • 59.6%患者接受保乳手术,33.4%接受单侧乳房切除术,7.0%接受CPM。
  • CPM比例从2002年3.9%上升至2012年12.7%(P < 0.001)。
  • CPM患者重建手术率48.3%,单侧乳房切除术患者16.0%;CPM患者重建率从2002年35.3%升至2012年55.4%(P < 0.001)。
  • 与保乳治疗相比,CPM未显著改善乳腺癌特异性生存(HR 1.08,95%CI 1.01-1.16)或总生存(HR 1.08,95%CI 1.03-1.14),无论激素受体状态或年龄。

临床怎么用

  • 临床咨询时应告知患者CPM相较于保乳治疗无生存获益证据。
  • 需结合患者年龄、激素受体状态等因素个体化讨论手术方式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To update and examine national temporal trends in contralateral prophylactic mastectomy (CPM) and determine whether survival differed for invasive breast cancer patients based on hormone receptor (HR) status and age. METHODS: We identified women diagnosed with unilateral stage I to III breast cancer between 1998 and 2012 within the Surveillance, Epidemiology, and End Results registry. We compared characteristics and temporal trends between patients undergoing breast-conserving surgery, unilateral mastectomy, and CPM. We then performed Cox proportional-hazards regression to examine breast cancer-specific survival (BCSS) and overall survival (OS) in women diagnosed between 1998 and 2007, who underwent breast-conserving surgery with radiation (breast-conserving therapy), unilateral mastectomy, or CPM, with subsequent subgroup analysis stratifying by age and HR status. RESULTS: Of 496,488 women diagnosed with unilateral invasive breast cancer, 59.6% underwent breast-conserving surgery, 33.4% underwent unilateral mastectomy, and 7.0% underwent CPM. Overall, the proportion of women undergoing CPM increased from 3.9% in 2002 to 12.7% in 2012 (P < 0.001). Reconstructive surgery was performed in 48.3% of CPM patients compared with only 16.0% of unilateral mastectomy patients, with rates of reconstruction with CPM rising from 35.3% in 2002 to 55.4% in 2012 (P < 0.001). When compared with breast-conserving therapy, we found no significant improvement in BCSS or OS for women undergoing CPM (BCSS: HR 1.08, 95% confidence interval 1.01-1.16; OS: HR 1.08, 95% confidence interval 1.03-1.14), regardless of HR status or age. CONCLUSIONS: The use of CPM more than tripled during the study period despite evidence suggesting no survival benefit over breast conservation. Further examination on how to optimally counsel women about surgical options is warranted.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Wong SM, Freedman RA, Sagara Y, et al. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer. Ann Surg. 2017. PMID: 28169929. doi:10.1097/SLA.0000000000001698

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。